Losartan can dissolve peritumoral collagen, significantly increase the effectiveness of chemo, reduce ascites, and block intratumoral blood vessel formation. Retrospective analyses show that losartan users have 30 months longer overall survival compared to patients with other blood pressure lowering drugs.   Tumor stroma – the unknown quantity I became aware of the potency of sartans … Continue reading Blood pressure lowering sartans as cancer adjuvants – 30 month OLT extension for ovarian cancer | F